Janney Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
SDH
EP
Janney Capital Management's ARKG Position: Q1 2021 in Review
Janney Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2021, closing a stake of 159,962 shares — an estimated $14.9M sold.
Janney Capital Management first reported a position in ARKG in Q3 2020 and held it in 2 quarters. The position peaked at $14.9M in Q4 2020. 505 funds tracked by Wall St. Rank hold ARKG as of Q1 2021.
- Janney Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2021 after selling out during the quarter.
- Janney Capital Management sold 159,962 ARK Genomic Revolution ETF shares in Q1 2021, an estimated $14.9M.
- Janney Capital Management first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 2 quarters.
- Janney Capital Management's ARK Genomic Revolution ETF position peaked at $14.9M in Q4 2020.
- 505 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2021.
Based on Janney Capital Management's 13F filing for Q1 2021, filed 27 Apr 2021.